Delivery Order 36C25624D0071-36C25624N0908

Award Date 9/1/24
Potential Completion Date 8/31/29
Potential Value $902K
Contracting Federal Agency
Veterans Integrated Service Network 16
Awardee
Sofie CO.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract, valued at $2,363,711.60, is for the ordering of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The contract has a period of performance through December 31, 2025 and is a firm fixed-price contract. Sofie is an established supplier of...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,172,834.00 firm-fixed-price delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical PYLARIFY F-18 DCFPYL, a molecular diagnostic for prostate cancer detection. The contract has a period of performance through May 31, 2025. Sofie CO. is an experienced prime contractor providing radiopharmaceuticals,...
The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
The U.S. Department of Veterans Affairs (VA) awarded a $75,783.12 firm-fixed-price purchase order contract to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical used in prostate cancer detection. This contract is part of Sofie's broader supply of specialized imaging agents, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. Sofie has...
The Department of Veterans Affairs (VA) awarded a $866,092.80 firm fixed-price purchase order to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for PYLARIFY radiopharmaceuticals. This contract is for the delivery of the PYLARIFY PET imaging agent to support prostate cancer detection programs within the VA's Veterans Integrated Service Network (VISN) 17. Sofie CO. has extensive experience supplying specialized radiopharmaceuticals and related services to various federal agencies, including...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
This federal contract award is for the delivery of radiopharmaceuticals and related services to the Department of Veterans Affairs (VA). The prime contractor, Sofie CO., is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals. The contract has a ceiling value of $90,125.00 and is a firm-fixed-price delivery order, with an ultimate completion date of September 30, 2020. The contract is...
This is a federal purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical F19, with a ceiling value of $17,535.00 and a period of performance ending on June 30, 2022. The contract has no set-aside designation. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the VA,...
This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
  • 36C25624D0071
    Indefinite Delivery Contract
  • 36C25624D0071-36C25624N0908
    Delivery Order

This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY F-18 isotopes. The contract has a ceiling value of $902,180.00 and runs through August 31, 2029. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals for medical imaging and cancer treatment. The contract supports the VA's prostate cancer detection programs across its healthcare facilities. Sofie also holds several other Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency (DHA) for the ongoing supply of its specialized radiopharmaceuticals and related services, valued at up to $5.86 million and $1.7 million, respectively. The contract does not have a set-aside designation.

Generated 3/25/25, 9:52 AM